1. Home
  2. LZM vs RGNX Comparison

LZM vs RGNX Comparison

Compare LZM & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifezone Metals Limited

LZM

Lifezone Metals Limited

HOLD

Current Price

$4.00

Market Cap

385.4M

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.96

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZM
RGNX
Founded
2021
2008
Country
Isle of Man
United States
Employees
142
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
385.4M
418.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
LZM
RGNX
Price
$4.00
$8.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$7.00
$28.75
AVG Volume (30 Days)
306.9K
605.4K
Earning Date
03-19-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$86.37
$50.15
Revenue Next Year
$202.49
$23.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$2.90
$5.16
52 Week High
$6.23
$16.19

Technical Indicators

Market Signals
Indicator
LZM
RGNX
Relative Strength Index (RSI) 53.77 52.47
Support Level $3.60 $7.78
Resistance Level $4.38 $9.28
Average True Range (ATR) 0.27 0.52
MACD 0.11 0.14
Stochastic Oscillator 84.68 77.35

Price Performance

Historical Comparison
LZM
RGNX

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: